Corrigendum to “Towards targeted cancer therapy: synthesis, characterization, and biological activity of a new Cu(II)-ibuprofen-2,2′-dipyridylamine metal complex” [Heliyon Volume 11, Issue 1, January 2025, Article e41323]
Year: 2025
Type: erratum
Abstract: In this article, one citation was incorrectly referenced, two citations were misplaced, and one sentence required revision for improved clarity. The authors have prepared an updated version of the manuscript incorporating the necessary corrections.
Source: Heliyon
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,270
OpenAlex ID: W4415899666
